Dr. Michael Law is an Assistant Professor in the Centre for Health Services and Policy Research at the University of British Columbia. He completed a PhD in Health Policy at Harvard University and a post-doctoral fellowship at Harvard Medical School, where he trained in research methods and statistics. His research focuses on pharmaceutical policy and has included studies on drug coverage changes, direct-to-consumer advertising, generic drug prices and the affordability of prescription drugs.
He has been published in leading medical journals, has received both national and international awards and has been featured in news media such as New Scientist, Forbes, the Globe & Mail, The Vancouver Sun and USA Today. Since his appointment at UBC he has received several notable awards, including the Labelle Lectureship at McMaster University, the 2011 Paper of the Year Award from the CIHR Institute for Health Services and Policy Research, a CIHR New Investigator Award, and a Michael Smith Foundation for Health Research Scholar Award.
Commentaries by Dr. Michael Law:
It’s time to reconsider private drug plans for public employees
Generic drug prices in Alberta: A step in the right direction
Canadians pay too much for generic drugs
Manufacturing anxiety about generic drug prices
This work is licensed under a Creative Commons Attribution 4.0 International License.